immunotherapy

The next generation of immunotherapy? Innate Pharma targets NK cells

https://pharmaphorum.com/views-and-analysis/the-next-generation-of-immunotherapy-innate-pharma/

Triple Negative Breast Cancer Drug Development Digital Summit

https://pharmaphorum.com/events/triple-negative-breast-cancer-drug-development-digital-summit/

Pfizer deal paves way for approval of ImaginAb’s cancer imaging tech

https://pharmaphorum.com/news/pfizer-deal-could-help-approval-of-imaginabs-cancer-imaging-tech/

2020 in review: Pharma’s progress outside of COVID-19

https://pharmaphorum.com/views-analysis-oncology/2020-review-pharmas-progress-outside-of-covid-19/

Cytokine-Based Cancer Immunotherapies Summit

https://pharmaphorum.com/events/cytokine-based-cancer-immunotherapies-summit/

Jounce shares crash after it abandons immunotherapy combination trial

https://pharmaphorum.com/news/jounce-shares-crash-after-it-abandons-immunotherapy-combination-trial/

ANGLE raises £20m, eyes opportunity in immunotherapy trials

https://pharmaphorum.com/news/angle-raises-20m-eyes-opportunity-for-parsortix-in-immunotherapy-trials/

Junshi plans filings after toripalimab hits target in upper throat cancer

https://pharmaphorum.com/news/junshi-plans-filings-after-toripalimab-hits-target-in-upper-throat-cancer/

Merck KGaA takes second option from cancer immunotherapy pact with F-Star

https://pharmaphorum.com/news/merck-kgaa-takes-second-option-from-cancer-immunotherapy-pact-with-f-star/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search